The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma

Virchows Archiv

Volumn 433, Issue 5, 1998, Pages 427-433

  Stoll, Christian ^a   Baretton, Gustavo ^b   Löhrs, Udo ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Immunohistochemistry; Oral, squamous cell carcinoma; Prognosis; Tumour suppress or gene

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031783067     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050270     Document Type: Article

References (39)

1. Barak Y, Gottlieb R, Juven-Gershon T, Oren M (1994) Regulation of mdm2 expression by p53: alternative promotors produce transcripts with nonidentical translation potential. Genes Dev 8:1739-1749
2. Barten M, Ostwald C, Müller P, Löning T, Milde-Langosch K, Wukasch Y (1994) P53 Alterationen und HPV Status in oralen Plattenepithelkarzinomen. Verh Dtsch Ces Pathol 78:255-259
3. Battifora H (1994) P53 immunohistochemistry: a word of caution. Hum Pathol 25:435-437
4. Bier J (1982) Definition zum radikalchirurgischen Vorgehen bei Plattenepithelkarzinomen der Mundhöhle. Dtsch Z Mund Kiefer Gesichtschir 6:369-372
5. Burns JE, Baird MC, Clark LJ, Burns PA, Edington K, Chapman C, Mitchell R, Robertson G, Soutar D, Parkinson EK (1993) Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 67:1274-1284
6. Cordon-Cardo C (1995) Mutation of cell cycle regulators. Am J Pathol 147:545-560
7. Dazard JE, Augias D, Neel H, Mils V, Marechal V, Basset-Seguin N, Piette J (1997) MDM-2 protein is expressed in different layers of normal human skin. Oncogene 14:1123-1128
8. El-Deiry WS, Tokino T, Velkulescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
9. Fakharzadeh SS, Trusko SP, George DL (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10:1565-1569
10. Fröhlich M (1991) Epidemiologie der Lippen- und Mundschleimhautkarzinome. Med Aktuell 17:180-181
11. Gehan EH (1965) A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203-223
12. Gorgoulis VG, Rassidakis GZ, Karameris AM, Papastamatiou H, Trigidou R, Veslemes M, Rassidakis AN, Kittas C (1996) Immunohistochemical and molecular evaluation of the mdm-2 gene product in brochogenic carcinoma. Mod Pathol 9:544-554
13. Greenblatt MS, Benett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
14. Hall PA, Lane DP (1994) P53 in tumour pathology: can we trust immunohistochemistry? - revisited. J Pathol (Lond) 172:1-4
15. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) P53 mutations in human cancers. Science 253:49-53
16. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481
17. Lane DP (1992) P53, guardian of the genome. Nature 358: 15-16
18. Langdon JD, Partridge M (1992) Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg 30:214-220
19. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453-456
20. Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 18:50-60
21. Mantel N (1967) Ranking procedures for arbitrarily restricted observations. Biometrics 23:65-78
22. Matsumura T, Yoshihama Y, Kimura T, Shintani S, Alcalde RE (1996) p53 and MDM 2 expression in oral squamous cell carcinoma. Oncology 53:308-312
23. Matsuta M, Kon S, Sasaki K, Matsuta M (1997) Immunohistochemical detection of p21 WAF1/CIP1 and p53 proteins in formalin-fixed paraffin-embedded tissue sections of squamous cell carcinoma of the skin. J Dermatol Sci 14:233-239
24. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395
25. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm2-oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245
26. Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M (1993) Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 50:426-429
27. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98
28. Piffko J, Bankfalvi A, Öfner D, Joos U, Böcker W, Schmid KW (1995) Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. J Pathol (Lond) 176:69-75
29. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I (1997) Histological typing of cancer and precancer of the mucosa, 2nd edn. Springer, Berlin Heidelberg New York
30. Pruneri G, Pignataro L, Carboni N, Luminari S, Capaccio P, Neri A, Buffa R (1997) MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation. Mod Pathol 10:785-792
31. Raycroft L, Wu H, Lozano G (1990) Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051
32. Shapiro SS, Wilk MB, Chen HJ (1968) A comparative study of various tests of normality. J Am Statist Assoc 63:1343-1372
33. Shintani S, Yoshihama Y, Emilio AR, Matsumura T (1995) Overexpression of p53 is an early event in the tumorigenesis of oral squamous call carcinomas. Anticancer Res 15:305-308
34. Sobin LH, Wittekind C (eds) (1997) UICC TNM classification of malignant tumours, 5th edn. Wiley-Liss, New York
35. Stenger JE, Mayr GA, Mann K, Tegtmeyer P (1992) Formation of stable p53 homotetramers and multiples of tetramers. Mol Carcinog 5:102-106
36. Vogelstein B, Kinzler KW (1992) P53 function and dysfunction. Cell 70:523-526
37. Vojtêsek B, Bártek J, Midgley CA, Lane DP (1992) An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151:237-244
38. Warnakulasuriya KA, Johnson NW (1992) Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 21: 404-408
39. Wynford-Thomas D (1992) P53 in tumour pathology: can we trust immunocytochemistry? J Pathol (Lond) 166:329-330